Cleared Traditional

K254102 - Glucommander

K254102 is an FDA 510(k) clearance for Glucommander, manufactured by Glytec, LLC. The device is a Class 2 Chemistry device with product code NDC cleared through the Traditional 510(k) pathway after a 159-day FDA review.

K254102 · Glytec, LLC · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2026
Decision
159d
Days
Class 2
Risk

K254102 is an FDA 510(k) clearance for the Glucommander. Classified as Calculator, Drug Dose (product code NDC), Class II - Special Controls.

Submitted by Glytec, LLC (Greenville, US). The FDA issued a Cleared decision on May 27, 2026 after a review of 159 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 868.1890 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Glytec, LLC devices

FDA 510(k) Submission Details - K254102

510(k) Number K254102 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2025
Decision Date May 27, 2026
Days to Decision 159 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized Yes - Predetermined Change Control Plan authorized FDA has pre-authorized specific future modifications to this device, a pathway common in AI/SaMD devices.
Regulatory Context
Review time vs. panel average
71d slower than avg
Panel avg: 88d · This submission: 159d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. PCCP authorized - AI/SaMD pathway.

NDC Device Classification - Class 2, Special Controls

Product Code NDC Calculator, Drug Dose
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NDC Calculator, Drug Dose

All 42
Devices cleared under the same product code (NDC) and FDA review panel - the closest regulatory comparables to K254102.
EndoTool IV Cloud 1.0
K260910 · Glooko, Inc. · May 2026
MiniMed Go App
K253512 · Medtronic Minimed · Jan 2026
UpDoc
K253281 · Updoc, Inc. · Dec 2025
T1D1
K252104 · Comerge AG · Aug 2025
EndoTool IV (3.1)
K241088 · Monarch Medical Technologies · Dec 2024
InPen System App (MMT-8060 (iOS), MMT-8061 (Android))
K242775 · Medtronic Minimed · Nov 2024